查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722456

2025-2033年肾臟生物标记市场报告（按生物标记类型、诊断技术、最终用户和地区）

Renal Biomarkers Market Report by Biomarker Type, Diagnostic Technique, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球肾臟生物标记市场规模达 14 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 26 亿美元，2025-2033 年期间的成长率 (CAGR) 为 6.54%。日益增长的公共卫生问题及其主要风险因素（包括高血压、糖尿病和心臟病）正在推动市场发展。

肾臟生物标记是尿液分析中存在的细胞、蛋白质、脂质、微小RNA、基因、代谢物或蛋白质体学模式。它们有助于确定肾臟的肾小球滤过率 (GFR)，以分析其正常功能并评估致病过程或对治疗介入的药理反应。由于肾臟生物标记也有助于预测病情进展和计算药物剂量，因此在全球各地的医院和诊断实验室中得到广泛的应用。

肾臟生物标记市场趋势：

慢性肾臟病（CKD）是一种发病率和死亡率较高的非传染性疾病，已逐渐成为全球公共卫生问题，其主要危险因子是糖尿病、高血压和心臟病。患有 CKD 的人数不断增加是推动市场成长的关键因素之一。此外，肾臟生物标记，包括血中尿素氮（BUN）、血清肌酸酐（SCr）、尿液白蛋白/蛋白和尿量排泄量，用于慢性肾臟病（CKD）的诊断和病情监测。除此之外，全球产业投资者对人类肾臟疾病的新型单一生物标记和製程特异性生物标记组的兴趣日益浓厚。这些新型生物标记提供了重要的诊断和预后讯息，并有助于预测对肾丝球病变、急性肾损伤 (AKI) 和常染色体显性多囊肾 (ADPKD) 的治疗反应。除此之外，肾臟生物标记在各种规模的实验室中变得越来越容易获得和可行。这与基因组学、表观遗传学、转录组学、蛋白质组学和代谢组学的发展和整合一起对市场产生了积极影响。预计其他一些因素，如蓬勃发展的医疗保健行业、不断增长的老年人口以及全球 CKD 临床试验数量的增加，也将促进市场的成长。

本报告回答的关键问题

  • 2024 年全球肾臟生物标记市场规模？ 2025 年至 2033 年期间全球肾臟生物标记市场的预期成长率为何？
  • COVID-19 对全球肾臟生物标记市场有何影响？
  • 推动全球肾臟生物标记市场发展的关键因素有哪些？
  • 根据生物标记类型，全球肾臟生物标记市场如何分布？
  • 根据诊断技术，全球肾臟生物标记市场如何分布？
  • 根据最终用户，全球肾臟生物标记市场是如何分布的？
  • 全球肾臟生物标记市场的主要区域有哪些？
  • 全球肾臟生物标记市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球肾臟生物标记市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依生物标誌类型

  • 功能性生物标记
    • 关键部分
      • 血清肌酸酐
      • 血清胱抑素C
      • 尿液白蛋白
  • 上调蛋白质
    • 关键部分
      • 中性粒细胞明胶酶相关脂质运载蛋白 (NGAL)
      • 肾损伤分子-1
      • 白血球介素-18
  • 其他的

第七章：市场区隔：透过诊断技术

  • 酵素连结免疫吸附试验（ELISA）
  • 颗粒增强免疫浊度分析法（PETIA）
  • 比色分析
  • 化学发光免疫分析（CLIA）
  • 液相层析质谱法（LC-MS）

第八章：市场区隔：按最终用户

  • 医院
  • 诊断实验室
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Beckman Coulter Inc. (Danaher Corporation)
    • bioMerieux SA
    • BioPorto A/S
    • Bio-Rad Laboratories Inc.
    • Enzo Biochem Inc.
    • F. Hoffmann-La Roche AG
    • PerkinElmer Inc.
    • Randox Laboratories Ltd.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A5273

The global renal biomarkers market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.54% during 2025-2033. The increasing public health concerns and its main risk factors, including hypertension, diabetes, and heart diseases, are bolstering the market.

Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular filtration rate (GFR) of kidneys to analyze their proper functioning and evaluating pathogenic processes or pharmacological responses to therapeutic interventions. As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.

Renal Biomarkers Market Trends:

Chronic kidney disease (CKD), non-communicable disease with considerable morbidity and mortality, has gradually become a public health concern globally and its main risk factors are diabetes, hypertension and heart diseases. The increasing number of individuals with CKD represents one of the key factors propelling the growth of the market. Moreover, renal biomarkers, including blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin/protein and volume excretion, are used in the diagnosis of chronic kidney disease (CKD) and monitoring of the disease. Besides this, there is a growing interest of industry investors in novel single biomarkers and process-specific biomarker panels in human renal diseases around the world. These novel biomarkers provide vital diagnostic and prognostic information and help predict response to the treatment of glomerulopathies, acute kidney injury (AKI), and autosomal dominant polycystic kidney disease (ADPKD). Apart from this, renal biomarkers are becoming accessible and feasible in all-sized laboratories. This, along with the development and integration of genomics, epigenetics, transcriptomics, proteomics, and metabolomics, is positively influencing the market. Some of the other factors, such as the burgeoning healthcare industry, the rising geriatric population, and the increasing number of clinical trials for CKD worldwide, are anticipated to facilitate the growth of the market.

Key Market Segmentation:

Breakup by Biomarker Type:

  • Functional Biomarker
  • Serum Creatinine
  • Serum Cystatin C
  • Urine Albumin
  • Up-regulated Protein
  • Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  • Kidney Injury Molecule-1
  • INTERLEUKIN-18
  • Others

Breakup by Diagnostic Technique:

  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Particle-enhanced Turbidimetric Immunoassay (PETIA)
  • Colorimetric Assay
  • Chemiluminescent Enzyme Immunoassay (CLIA)
  • Liquid Chromatography Mass Spectrometry (LC-MS)

Breakup by End User:

  • Hospital
  • Diagnostic Laboratory
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global renal biomarkers market in 2024?
  • 2.What is the expected growth rate of the global renal biomarkers market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global renal biomarkers market?
  • 4.What are the key factors driving the global renal biomarkers market?
  • 5.What is the breakup of the global renal biomarkers market based on the biomarker type?
  • 6.What is the breakup of the global renal biomarkers market based on the diagnostic technique?
  • 7.What is the breakup of the global renal biomarkers market based on end user?
  • 8.What are the key regions in the global renal biomarkers market?
  • 9.Who are the key players/companies in the global renal biomarkers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Renal Biomarkers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Biomarker Type

  • 6.1 Functional Biomarker
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Serum Creatinine
      • 6.1.2.2 Serum Cystatin C
      • 6.1.2.3 Urine Albumin
    • 6.1.3 Market Forecast
  • 6.2 Up-regulated Protein
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Neutrophil Gelatinase-Associated Lipocalin (NGAL)
      • 6.2.2.2 Kidney Injury Molecule-1
      • 6.2.2.3 INTERLEUKIN-18
    • 6.2.3 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Diagnostic Technique

  • 7.1 Enzyme-linked Immunosorbent Assay (ELISA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Particle-enhanced Turbidimetric Immunoassay (PETIA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Colorimetric Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Chemiluminescent Immunoassay (CLIA)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Liquid Chromatography Mass Spectrometry (LC-MS)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratory
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 BioPorto A/S
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Biochem Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 PerkinElmer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Randox Laboratories Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Siemens AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Renal Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Renal Biomarkers Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Renal Biomarkers Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Renal Biomarkers Market: Breakup by Biomarker Type (in %), 2024
  • Figure 5: Global: Renal Biomarkers Market: Breakup by Diagnostic Technique (in %), 2024
  • Figure 6: Global: Renal Biomarkers Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Renal Biomarkers Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Renal Biomarkers (Functional Biomarker) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Renal Biomarkers (Functional Biomarker) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Renal Biomarkers (Up-regulated Protein) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Renal Biomarkers (Up-regulated Protein) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Renal Biomarkers (Other Biomarker Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Renal Biomarkers (Other Biomarker Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Renal Biomarkers (Colorimetric Assay) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Renal Biomarkers (Colorimetric Assay) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Renal Biomarkers (Hospital) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Renal Biomarkers (Hospital) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Renal Biomarkers (Diagnostic Laboratory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Renal Biomarkers (Diagnostic Laboratory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Renal Biomarkers (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Renal Biomarkers (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Renal Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Renal Biomarkers Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Renal Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Renal Biomarkers Industry: SWOT Analysis
  • Figure 80: Global: Renal Biomarkers Industry: Value Chain Analysis
  • Figure 81: Global: Renal Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Renal Biomarkers Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Renal Biomarkers Market Forecast: Breakup by Biomarker Type (in Million USD), 2025-2033
  • Table 3: Global: Renal Biomarkers Market Forecast: Breakup by Diagnostic Technique (in Million USD), 2025-2033
  • Table 4: Global: Renal Biomarkers Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Renal Biomarkers Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Renal Biomarkers Market: Competitive Structure
  • Table 7: Global: Renal Biomarkers Market: Key Players